Accepted at 11:42 p.m. Feb, 27, 2024 by Cameron
Author: ymh
Related Note: 1518968305406
Rationale for change

no cards outlining what the mechanism of anakinra is–might be a good addition to include that it is an IL-1 receptor antagonist

source (https://www.kineretrx.com/) - company that manufactures anakinra
Source: Other - https://www.kineretrx.com/

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::25917 #AK_Step1_v12::^Systems::Musculoskeletal::Pharmacology #AK_Step1_v12::#OME_banner::Basic_Science::07_Immunology #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::02_Recombinant_cytokines_and_clinical_uses::02_Immunotherapy::*Anakinra #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::01_Rheumatoid_Arthritis #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#UWorld::Step::14677 #AK_Step1_v12::#SketchyPharm::Miscellaneous_Pharm #AK_Step1_v12::#Physeo::11_Pathology::04_Musculoskeletal_Pathology::04_Osteoarthritis_Rheumatoid_Arthritis !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Pixorize::02_Immunology::05_Cytokines::02_IL-1 #AK_Step1_v12::^Other::^EXPN::BGadd #PANCE::EOR::IM #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step2_v12::#SketchyIM::07_Rheumatology::Retired_Lessons::02_Systemic_Rheumatic_Diseases::01_Rheumatoid_Arthritis_SOAP_[OLD_VERSION] #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::01_Rheumatoid_Arthritis #AK_Step2_v12::#SketchyPeds::14_Rheumatology::03_Retired_Lessons::03_Juvenile_Idiopathic_Arthritis_SOAP_[OLD_VERSION]